Find a world of support about living as a young woman with primary breast cancer.
Younger Women Together Online
If you’re under 45 and have had a primary breast cancer diagnosis within the last three years, our new Younger Women Together Online service is just for you. In a confidential online space, you’ll meet other women your age who understand what you’re going through and be able to access expert information on treatment, fertility, exercise and more.
Our upcoming series start on the below dates. Please select a date to find out more and register:
Younger Women Together Speakers Live
Do you want to learn more about healthy eating, exercise and returning to work? Come along to our live talks by expert speakers via Zoom webinar – you can attend all of them or select the ones which interest you.
There will be an opportunity to send questions before or during the talk.
Younger Women Together Online has been created whilst Breast Cancer Now’s face-to-face services are suspended due to the Covid-19 crisis. We’re always with you, even when we can’t get to you.
Our speakers events take place on the below dates:
Monday 27 September Menopausal Symptoms with Carolyn Rogers
Carolyn Rogers is a senior Clinical Nurse Specialist at Breast Cancer Now. Prior to this she worked as a Clinical Nurse Specialist in the NHS for many years. She is passionate about supporting women in managing and coping with menopausal symptoms that can occur as a consequence of some breast cancer treatments.
Wednesday 29 September Exercise with Carolyn Garritt
Carolyn Garritt is a personal trainer who specialises in helping people to get fit and active before, during and after cancer treatment. She firmly believes that exercise should be enjoyable, uplifting and a positive part of our daily lives.
Carolyn set up Oomph after 20 years’ experience in NHS Cancer Services and after helping her mum train to run a 5k race following treatment for breast cancer. Carolyn runs regular sessions for visitors to the London Maggie’s Centre and the Breast Cancer Haven, as well as training people from her base in Hyde Park. She is a very keen Nordic Walking Instructor.
Wednesday 6 October Managing work and Cancer with Maggie Newton
Maggie joined the Working with Cancer team in 2016. She finds it extremely rewarding to be able to support those affected by cancer at work through drawing on her own experiences. She was successfully treated for breast cancer in 2014 and then thyroid cancer in 2017. Despite having a strong support network of family and friends there were times when she felt very alone and being able to share feelings with colleagues who’d also been through cancer was immensely beneficial. She enjoys being able to use her knowledge and coaching skills to help clients rebuild their confidence and set realistic goals. She also delivers employer support for WWC as it is really important for line managers, and HR professionals, to fully understand the impact cancer may have on staff, and how to handle communications sensitively.
Maggie started her management career at Crest Hotels before moving into communication focussed roles at Kraft Foods, Barclaycard and WRAP (Waste & Resources Action Programme). She has extensive experience in effective communications, getting the best out of people and developing resilience, particularly in times of significant change. When her breast cancer diagnosis coincided with redundancy, this provided her with the motivation and incentive needed to start her own coaching business.
Maggie qualified as a coach with the Coaching Academy and is also accredited to use DISC personality profiling. She cares deeply about helping clients find their feet again emotionally after cancer and clients describe her as kind, passionate and knowledgeable
Monday 18 October Healthy Eating with Nathalie Jones
Nathalie Jones is a freelance dietitian based in Glasgow, she has worked in the NHS and in private practice. She qualified in 2003 in general community dietetics, covering all aspects of dietary care before specialising in weight management and sports nutrition. Nathalie has enjoyed running healthy eating sessions for Breast Cancer Now since January 2009.
Thursday 21 October Hormone treatments in younger women with breast cancer with Dr Marina Parton
Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden. Appointed to The Royal Marsden Consultant Body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research with Professors Dowsett and Professor Smith.
Dr Parton is Lead Cancer Clinician in The Royal Marsden’s satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support as well as leading breast clinics at The Royal Marsden in Chelsea. She has published in breast cancer research, and is principle investigator in a number of clinical trials at The Royal Marsden. She has previously been Chair of the Acute Oncology Group at The Royal Marsden, part of the Breast Pathway Group at London Cancer Alliance (LCA) and co chair of the LCA Chemotherapy Closer to Home Group. She is involved in a number of national educational groups and meetings in early and secondary breast cancer, and co edited Breast Cancer Survivorship; consequences of early breast cancer treatment. Dr Parton was member of the NICE Early Breast Guidelines update (published 2018).
Thursday 4 November 2pm-3:30pm - Triple Negative Breast Cancer in Younger Women with Professor Peter
Professor Schmid is internationally recognized for his research and education leadership in breast cancer. He is the clinical director of the Breast Cancer Centre and an honorary consultant medical oncologist at St. Bartholomew’s Hospital. He was appointed in 2013 as Chair in Cancer Medicine at Barts Cancer Institute (BCI), Queen Mary University, London. Professor Schmid is also Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute, overseeing the conduct of early phase trials at St. Bartholomew’s Hospital and BCI, with a particular interest in Immunotherapy, innovative trial designs, and circulating biomarkers. He leads the academic breast cancer programme at St. Bartholomew’s Hospital and BCI.
Prof Schmid graduated from the Technical University of Munich medical school in 1997, gaining a MD in Clinical Chemistry in 1998 from the University of Munich and a Clinical Research PhD in 2005 from Charité University in Berlin. He trained at the University Hospital Charité in Berlin in internal medicine, haematology, and oncology, before he became a Senior Clinical Lecturer and Director of the Hammersmith Early Clinical Trials Unit at Imperial College London in 2005. Professor Schmid was appointed as Foundation Chair in Cancer Medicine at the University of Sussex in 2010 before taking on his current role at BCI in 2013.
Professor Schmid’s primary research interest is in clinical research in breast cancer with the goal of improving the treatment of women with breast cancer by defining more effective and less toxic approaches. Specific research areas include cancer immune therapy, triple-negative breast cancer, endocrine resistance, and innovative biomarker-driven trial concepts. Professor Schmid runs an international collaborative clinical and translational research programme.
Professor Schmid is the principal investigator of several pivotal breast cancer studies, including the Impassion130 trial that evaluated atezolizumab for advanced triple-negative breast cancer and led to the regulatory approval of the first immunotherapy strategy for patients with breast cancer, establishing a new standard of care of this disease. Professor Schmid is also the lead investigator of the KEYNOTE-522 trial which evaluated the immune-checkpoint inhibitor Pembrolizumab in combination with neoadjuvant chemotherapy for early triple-negative breast cancer and demonstrated a significant increase in pathological response rates. His work has been published in many journals including the New England Journal of Medicine, Lancet, Lancet Oncology, JAMA Oncology, Nature Communications and the Journal of Clinical Oncology.
Prof Schmid is a member of several national and international cancer organisations and research groups and has been involved in international consensus meetings on the management of breast cancer. Professor Peter Schmid is a member of the European Society for Medical Oncology (ESMO) breast cancer faculty.